{
  "id": "5f1952ebc50eaadf",
  "title": "STAT+: Pharmalittle: We\u2019re reading about a potential Merck purchase, a J&J pricing deal with Trump, and more",
  "description": "Merck is in talks to buy cancer drug developer Revolution Medicines\u00a0in a deal that may be worth $28 billion to $32 billion",
  "content": "Merck is in talks to buy cancer drug developer Revolution Medicines\u00a0in a deal that may be worth $28 billion to $32 billion",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/09/lilly-zepbound-jnj-merck-biotech-pharma/?utm_campaign=rss",
  "published_at": "2026-01-09T14:31:56+00:00",
  "fetched_at": "2026-01-10T00:22:56.872596+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about a potential Merck purchase, a J&J pricing deal with Trump, and more",
    "description": "Merck is in talks to buy cancer drug developer Revolution Medicines\u00a0in a deal that may be worth $28 billion to $32 billion",
    "url": "https://www.statnews.com/pharmalot/2026/01/09/lilly-zepbound-jnj-merck-biotech-pharma/?utm_campaign=rss",
    "published": "2026-01-09T14:31:56+00:00",
    "source": "STAT"
  }
}